Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001493152-25-007179·Baharaff Allen
Schedule 13G ownership disclosure
GALMED PHARMACEUTICALS LTD
Ordinary shares, NIS 1.80 par value per share · CUSIP: M47238148
Event date: 2024-12-31
- Filing-level shares
- 44,128.00
- Percent of class
- 2.6%
- Allen Baharaff
Shares: 44,128.00 · Class: 2.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-007179
- Form type
- SCHEDULE 13G/A
- Filer
- Baharaff Allen
- CIK
- CIK 1630334
- Filed
- Feb 18, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership